搜索筛选:
搜索耗时5.3004秒,为你在为你在102,285,761篇论文里面共找到 5 篇相符的论文内容
类      型:
[会议论文] 作者:Xingyang Yi,Biao Zhang,Chun Wang,Duanxiu Liao,Jing Lin,Lifen Chi, 来源:四川省医学会第十三次神经病学学术会议 年份:2014
Stroke is the second leading cause of death in developed countries.Ischemic stroke (IS), the most common type of stroke, s a multi-factorial disease caused by a combination of environmental risk facto...
[会议论文] 作者:Xingyang Yi,Biao Zhang,Chun Wang,Duanxiu Liao,Jing Lin,Lifen Chi, 来源:四川省医学会第十三次神经病学学术会议 年份:2014
Objective: CYP4A11 and CYP4F2 are responsible for metabolizing arachidonic acid (AA) into 20-hydroxyeicosatetraenoic acid (20-HETE), a vasoconstrictor.The aim of the present study was to evaluate the...
[会议论文] 作者:Xingyang Yi,Chun Wang,Biao Zhang,Duanxiu Liao,Jing Lin,Lifen Chi, 来源:中国脑卒中大会2016暨第六届全国心脑血管病论坛、2016中国脑卒中大会中西医结合心脑血管病论坛、世界中医药学会联合会脑 年份:2016
Objectives: To evaluate the prevalence and risk factors of antiplatelet drug resistance,and the association of antiplatelet drug resistance with early neurological deterioration (END) and recurrent is...
[会议论文] 作者:Xingyang Yi,Qiang Zhou,Chun Wang,Jing Lin,Wen Cheng,Lifen Chi, 来源:中国脑卒中大会2016暨第六届全国心脑血管病论坛、2016中国脑卒中大会中西医结合心脑血管病论坛、世界中医药学会联合会脑 年份:2016
Aim: Conflicting data exist as to whether proton-pump inhibitors (PPIs) diminish the efficacy of clopidogrel.We,therefore,assessed the effect of concomitant PPI use in ischemic stroke (IS) patients re...
[会议论文] 作者:Xingyang Yi,Yanfen Wang,Jing Lin,Wen Cheng,Qiang Zhou,Chun Wang,Lifen Chi, 来源:中国脑卒中大会2016暨第六届全国心脑血管病论坛、2016中国脑卒中大会中西医结合心脑血管病论坛、世界中医药学会联合会脑 年份:2016
Background: Clopidogrel is a clinically important oral antiplatelet agent for the treatment or prevention of cerebrovascular disease.However,different individuals have different sensitivities to Clopi...
相关搜索: